Thyrotoxicosis with toxic single thyroid nodule
ICD-10 E05.1 is a billable code used to indicate a diagnosis of thyrotoxicosis with toxic single thyroid nodule.
Thyrotoxicosis with toxic single thyroid nodule refers to a condition where an overactive thyroid nodule produces excess thyroid hormones, leading to symptoms of hyperthyroidism. This condition is characterized by elevated levels of thyroid hormones in the bloodstream, which can result from a solitary nodule that autonomously secretes these hormones. Patients may present with symptoms such as weight loss, increased appetite, anxiety, tremors, heat intolerance, and palpitations. Diagnosis typically involves thyroid function tests, including serum TSH, free T4, and T3 levels, alongside imaging studies like ultrasound to identify the nodule. Management may include antithyroid medications, radioactive iodine therapy, or surgical intervention, depending on the size of the nodule and the severity of symptoms. It is crucial to differentiate this condition from other forms of hyperthyroidism, such as Graves' disease or multinodular goiter, to ensure appropriate treatment.
Thorough documentation of thyroid function tests, imaging results, and clinical symptoms.
Patients presenting with symptoms of hyperthyroidism and a palpable thyroid nodule.
Endocrinologists must ensure that all relevant lab results and imaging studies are included in the patient's record to support the diagnosis.
Documentation of patient history, physical examination findings, and referral notes to specialists.
Initial evaluation of patients with symptoms suggestive of hyperthyroidism.
Primary care providers should document any referrals to endocrinology for further evaluation and management.
Used to evaluate thyroid hormone levels in patients suspected of having thyrotoxicosis.
Document the rationale for testing and results.
Endocrinologists may require additional tests such as TSH receptor antibodies.
Common symptoms include weight loss, increased appetite, anxiety, tremors, heat intolerance, and palpitations.
Diagnosis is made through thyroid function tests showing elevated T4 and T3 levels with suppressed TSH, along with imaging studies like ultrasound to identify the nodule.
